{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:55:12Z","timestamp":1792079712374,"version":"4.4.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T00:00:00Z","timestamp":1727395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science Assistance Project for Xinjiang","award":["2024E02062"],"award-info":[{"award-number":["2024E02062"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["3239014"],"award-info":[{"award-number":["3239014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82304575"],"award-info":[{"award-number":["82304575"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Provincial Basic and Applied Basic Research Fund","award":["2022A1515110883"],"award-info":[{"award-number":["2022A1515110883"]}]},{"name":"Young Scientists Program of Guangzhou Laboratory","award":["No. QNPG24-09"],"award-info":[{"award-number":["No. QNPG24-09"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-03949-0","type":"journal-article","created":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:24:51Z","timestamp":1727454291000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Evaluation of the impact of customized serum-free culture medium on the production of clinical-grade human umbilical cord mesenchymal stem cells: insights for future clinical applications"],"prefix":"10.1186","volume":"15","author":[{"given":"Lan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuangbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4859-3178","authenticated-orcid":false,"given":"Lijun","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,27]]},"reference":[{"issue":"6","key":"3949_CR1","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1038\/s41423-023-00998-y","volume":"20","author":"P Li","year":"2023","unstructured":"Li P, Ou Q, Shi S, Shao C. Immunomodulatory properties of mesenchymal stem cells\/dental stem cells and their therapeutic applications. Cell Mol Immunol. 2023;20(6):558\u201369.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"3949_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, Hedayati Asl AA, Abbasi Kakroodi F, Jaroughi N, Mohseni Meybodi MA, Setoodeh A, Abbasi F, Hosseini SE, Moeini Nia F, Salman Yazdi R, Navabi R, Hajizadeh-Saffar E, Baharvand H. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial. Stem Cell Res Ther. 2022;13(1):264.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"3949_CR3","doi-asserted-by":"publisher","first-page":"637239","DOI":"10.3389\/fcell.2021.637239","volume":"12","author":"Q Li","year":"2021","unstructured":"Li Q, Hou H, Li M, Yu X, Zuo H, Gao J, Zhang M, Li Z, Guo Z. CD73+ mesenchymal stem cells ameliorate myocardial infarction by promoting angiogenesis. Front Cell Dev Biol. 2021;12(9):637239.","journal-title":"Front Cell Dev Biol"},{"issue":"17","key":"3949_CR4","first-page":"369","volume":"19","author":"M Nie","year":"2022","unstructured":"Nie M, Kong B, Chen G, Xie Y, Zhao Y, Sun L. MSCs-laden injectable self-healing hydrogel for systemic sclerosis treatment. Bioact Mater. 2022;19(17):369\u201378.","journal-title":"Bioact Mater"},{"issue":"10","key":"3949_CR5","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1016\/j.ymthe.2023.07.024","volume":"31","author":"W Wang","year":"2023","unstructured":"Wang W, Zhang M, Ren X, Song Y, Xu Y, Zhuang K, Xiao T, Guo X, Wang S, Hong Q, Feng Z, Chen X, Cai G. Single-cell dissection of cellular and molecular features underlying mesenchymal stem cell therapy in ischemic acute kidney injury. Mol Ther. 2023;31(10):3067\u201383.","journal-title":"Mol Ther"},{"key":"3949_CR6","doi-asserted-by":"publisher","first-page":"101138","DOI":"10.1016\/j.mam.2022.101138","volume":"91","author":"DJ Beetler","year":"2023","unstructured":"Beetler DJ, Di Florio DN, Law EW, Groen CM, Windebank AJ, Peterson QP, Fairweather D. The evolving regulatory landscape in regenerative medicine. Mol Aspects Med. 2023;91:101138.","journal-title":"Mol Aspects Med"},{"issue":"4","key":"3949_CR7","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/med.21659","volume":"40","author":"J L\u00f3pez-Beas","year":"2020","unstructured":"L\u00f3pez-Beas J, Guadix JA, Clares B, Soriano-Ruiz JL, Zugaza JL, G\u00e1lvez-Mart\u00edn P. An overview of international regulatory frameworks for mesenchymal stromal cell-based medicinal products: from laboratory to patient. Med Res Rev. 2020;40(4):1315\u201334.","journal-title":"Med Res Rev"},{"key":"3949_CR8","doi-asserted-by":"publisher","first-page":"114356","DOI":"10.1016\/j.biopha.2023.114356","volume":"162","author":"M Al-Azab","year":"2023","unstructured":"Al-Azab M, Idiiatullina E, Safi M, Hezam K. Enhancers of mesenchymal stem cell stemness and therapeutic potency. Biomed Pharmacother. 2023;162:114356.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"3949_CR9","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells11091419","volume":"11","author":"D M\u00f6nch","year":"2022","unstructured":"M\u00f6nch D, Reinders MEJ, Dahlke MH, Hoogduijn MJ. How to make sense out of 75,000 mesenchymal stromal cell publications? Cells. 2022;11(9):1419.","journal-title":"Cells"},{"issue":"3","key":"3949_CR10","first-page":"310","volume":"12","author":"M Bahari","year":"2023","unstructured":"Bahari M, Mokhtari H, Yeganeh F. Stem cell therapy, the market, the opportunities and the threat. Int J Mol Cell Med. 2023;12(3):310\u20139.","journal-title":"Int J Mol Cell Med"},{"issue":"1","key":"3949_CR11","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41392-022-01134-4","volume":"7","author":"DM Hoang","year":"2022","unstructured":"Hoang DM, Pham PT, Bach TQ, Ngo ATL, Nguyen QT, Phan TTK, Nguyen GH, Le PTT, Hoang VT, Forsyth NR, Heke M, Nguyen LT. Stem cell-based therapy for human diseases. Signal Transduct Target Ther. 2022;7(1):272.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3949_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s13770-020-00306-z","volume":"18","author":"HTH Bui","year":"2021","unstructured":"Bui HTH, Nguyen LT, Than UTT. Influences of Xeno-free media on mesenchymal stem cell expansion for clinical application. Tissue Eng Regen Med. 2021;18(1):15\u201323.","journal-title":"Tissue Eng Regen Med"},{"issue":"15","key":"3949_CR13","doi-asserted-by":"publisher","first-page":"1404228","DOI":"10.3389\/fimmu.2024.1404228","volume":"14","author":"F Agostini","year":"2024","unstructured":"Agostini F, Vicinanza C, Lombardi E, Da Ros F, Marangon M, Massarut S, Mazzucato M, Durante C. Ex vivo expansion in a clinical grade medium, containing growth factors from human platelets, enhances migration capacity of adipose stem cells. Front Immunol. 2024;14(15):1404228.","journal-title":"Front Immunol"},{"issue":"11","key":"3949_CR14","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jcyt.2020.07.005","volume":"22","author":"A Winkel","year":"2020","unstructured":"Winkel A, Jaimes Y, Melzer C, Dillschneider P, Hartwig H, Stiesch M, von der Ohe J, Strauss S, Vogt PM, Hamm A, Burmeister L, Roger Y, Elger K, Floerkemeier T, Weissinger EM, Pogozhykh O, M\u00fcller T, Selich A, Rothe M, Petri S, K\u00f6hl U, Hass R, Hoffmann A. Cell culture media notably influence properties of human mesenchymal stroma\/stem-like cells from different tissues. Cytotherapy. 2020;22(11):653\u201368.","journal-title":"Cytotherapy"},{"issue":"1","key":"3949_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13287-021-02273-1","volume":"12","author":"K Nagasaki","year":"2021","unstructured":"Nagasaki K, Nakashima A, Tamura R, Ishiuchi N, Honda K, Ueno T, Doi S, Kato Y, Masaki T. Mesenchymal stem cells cultured in serum-free medium ameliorate experimental peritoneal fibrosis. Stem Cell Res Ther. 2021;12(1):203.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3949_CR16","doi-asserted-by":"publisher","first-page":"e00191","DOI":"10.1042\/BSR20150025","volume":"35","author":"I Ullah","year":"2015","unstructured":"Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells\u2013current trends and future prospective. Biosci Rep. 2015;35(2):e00191.","journal-title":"Biosci Rep"},{"issue":"6","key":"3949_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1002\/stem.1681","volume":"32","author":"FJ Lv","year":"2014","unstructured":"Lv FJ, Tuan RS, Cheung KM, Leung VY. Concise review: the surface markers and identity of human mesenchymal stem cells. Stem Cells. 2014;32(6):1408\u201319.","journal-title":"Stem Cells"},{"issue":"1","key":"3949_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/cyto.a.23242","volume":"93","author":"D Mushahary","year":"2018","unstructured":"Mushahary D, Spittler A, Kasper C, Weber V, Charwat V. Isolation, cultivation, and characterization of human mesenchymal stem cells. Cytom A. 2018;93(1):19\u201331.","journal-title":"Cytom A"},{"issue":"1","key":"3949_CR19","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12291-017-0641-x","volume":"33","author":"H Ghaneialvar","year":"2018","unstructured":"Ghaneialvar H, Soltani L, Rahmani HR, Lotfi AS, Soleimani M. Characterization and classification of mesenchymal stem cells in several species using surface markers for cell therapy purposes. Indian J Clin Biochem. 2018;33(1):46\u201352.","journal-title":"Indian J Clin Biochem"},{"issue":"4","key":"3949_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8(4):315\u20137.","journal-title":"Cytotherapy"},{"issue":"4","key":"3949_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/scrt477","volume":"5","author":"P Swamynathan","year":"2014","unstructured":"Swamynathan P, Venugopal P, Kannan S, Thej C, Kolkundar U, Bhagwat S, Ta M, Majumdar AS, Balasubramanian S. Are serum-free and xeno-free culture conditions ideal for large scale clinical grade expansion of Wharton\u2019s jelly derived mesenchymal stem cells? A comparative study. Stem Cell Res Ther. 2014;5(4):88.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3949_CR22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13287-019-1331-9","volume":"10","author":"J Czapla","year":"2019","unstructured":"Czapla J, Matuszczak S, Kulik K, Wi\u015bniewska E, Pilny E, Jarosz-Biej M, Smolarczyk R, Sirek T, Zembala MO, Zembala M, Szala S, Cicho\u0144 T. The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells. Stem Cell Res Ther. 2019;10(1):235.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"3949_CR23","doi-asserted-by":"crossref","first-page":"215517901875514","DOI":"10.1177\/2155179018755140","volume":"6","author":"JE Piletz","year":"2018","unstructured":"Piletz JE, Drivon J, Eisenga J, Buck W, Yen S, McLin M, Meruvia W, Amaral C, Brue K. Human cells grown with or without substitutes for fetal bovine serum. Cell Med. 2018;6(10):2155179018755140.","journal-title":"Cell Med"},{"issue":"3","key":"3949_CR24","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1182\/blood.V89.3.776","volume":"89","author":"TA Selvaggi","year":"1997","unstructured":"Selvaggi TA, Walker RE, Fleisher TA. Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood. 1997;89(3):776\u20139.","journal-title":"Blood"},{"issue":"13","key":"3949_CR25","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1089\/10430340260201699","volume":"13","author":"L Tuschong","year":"2002","unstructured":"Tuschong L, Soenen SL, Blaese RM, Candotti F, Muul LM. Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. Hum Gene Ther. 2002;13(13):1605\u201310.","journal-title":"Hum Gene Ther"},{"issue":"12","key":"3949_CR26","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1089\/ten.tec.2011.0255","volume":"17","author":"Fd Santos","year":"2011","unstructured":"Santos Fd, Andrade PZ, Abecasis MM, Gimble JM, Chase LG, Campbell AM, Boucher S, Vemuri MC, Silva CL, Cabral JM. Toward a clinical-grade expansion of mesenchymal stem cells from human sources: a microcarrier-based culture system under xeno-free conditions. Tissue Eng Part C Methods. 2011;17(12):1201\u201310.","journal-title":"Tissue Eng Part C Methods"},{"issue":"10","key":"3949_CR27","doi-asserted-by":"publisher","first-page":"750","DOI":"10.5966\/sctm.2012-0072","volume":"1","author":"LG Chase","year":"2012","unstructured":"Chase LG, Yang S, Zachar V, Yang Z, Lakshmipathy U, Bradford J, Boucher SE, Vemuri MC. Development and characterization of a clinically compliant xeno-free culture medium in good manufacturing practice for human multipotent mesenchymal stem cells. Stem Cells Transl Med. 2012;1(10):750\u20138.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"3949_CR28","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/s13287-021-02474-8","volume":"12","author":"S Bucar","year":"2021","unstructured":"Bucar S, Branco ADM, Mata MF, Milhano JC, Caramalho \u00cd, Cabral JMS, Fernandes-Platzgummer A, da Silva CL. Influence of the mesenchymal stromal cell source on the hematopoietic supportive capacity of umbilical cord blood-derived CD34+-enriched cells. Stem Cell Res Ther. 2021;12(1):399.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"3949_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1634\/stemcells.21-6-694","volume":"21","author":"P Denning-Kendall","year":"2003","unstructured":"Denning-Kendall P, Singha S, Bradley B, Hows J. Cobblestone area-forming cells in human cord blood are heterogeneous and differ from long-term culture-initiating cells. Stem Cells. 2003;21(6):694\u2013701.","journal-title":"Stem Cells"},{"issue":"3","key":"3949_CR30","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/term.143","volume":"3","author":"R Pal","year":"2009","unstructured":"Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2009;3(3):163\u201374.","journal-title":"J Tissue Eng Regen Med"},{"issue":"2021","key":"3949_CR31","first-page":"6659244","volume":"1","author":"P Tonarova","year":"2021","unstructured":"Tonarova P, Lochovska K, Pytlik R, Hubalek KM. The impact of various culture conditions on human mesenchymal stromal cells metabolism. Stem Cells Int. 2021;1(2021):6659244.","journal-title":"Stem Cells Int"},{"issue":"1","key":"3949_CR32","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1038\/s41598-021-83088-1","volume":"11","author":"S Bhat","year":"2021","unstructured":"Bhat S, Viswanathan P, Chandanala S, Prasanna SJ, Seetharam RN. Expansion and characterization of bone marrow derived human mesenchymal stromal cells in serum-free conditions. Sci Rep. 2021;11(1):3403.","journal-title":"Sci Rep"},{"issue":"1","key":"3949_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13045-016-0276-z","volume":"9","author":"K Zhao","year":"2016","unstructured":"Zhao K, Liu Q. The clinical application of mesenchymal stromal cells in hematopoietic stem cell transplantation. J Hematol Oncol. 2016;9(1):46.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"3949_CR34","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1038\/sj.leu.2404777","volume":"21","author":"K Le Blanc","year":"2007","unstructured":"Le Blanc K, Samuelsson H, Gustafsson B, Remberger M, Sundberg B, Arvidson J, Ljungman P, L\u00f6nnies H, Nava S, Ringd\u00e9n O. Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells. Leukemia. 2007;21(8):1733\u20138.","journal-title":"Leukemia"},{"issue":"1","key":"3949_CR35","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s13287-019-1287-9","volume":"10","author":"L Zhao","year":"2019","unstructured":"Zhao L, Chen S, Yang P, Cao H, Li L. The role of mesenchymal stem cells in hematopoietic stem cell transplantation: prevention and treatment of graft-versus-host disease. Stem Cell Res Ther. 2019;10(1):182.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3949_CR36","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s13287-023-03427-z","volume":"14","author":"ML Arango-Rodr\u00edguez","year":"2023","unstructured":"Arango-Rodr\u00edguez ML, Mateus LC, Sossa CL, Becerra-Bayona SM, Solarte-David VA, Ochoa Vera ME, Viviescas LTG, Berrio AMV, Serrano SE, Vargas O, Isla AC, Benitez A, Rangel G. A novel therapeutic management for diabetes patients with chronic limb-threatening ischemia: comparison of autologous bone marrow mononuclear cells versus allogenic Wharton jelly-derived mesenchymal stem cells. Stem Cell Res Ther. 2023;14(1):221.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3949_CR37","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s13287-021-02560-x","volume":"12","author":"L Pan","year":"2021","unstructured":"Pan L, Liu C, Liu Q, Li Y, Du C, Kang X, Dong S, Zhou Z, Chen H, Liang X, Chu J, Xu Y, Zhang Q. Human Wharton\u2019s jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-\u03baB signaling and glycolysis. Stem Cell Res Ther. 2021;12(1):496.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3949_CR38","doi-asserted-by":"publisher","first-page":"893","DOI":"10.7150\/thno.48080","volume":"11","author":"T Cheng","year":"2021","unstructured":"Cheng T, Ding S, Liu S, Li Y, Sun L. Human umbilical cord-derived mesenchymal stem cell therapy ameliorates lupus through increasing CD4+ T cell senescence via MiR-199a-5p\/Sirt1\/p53 axis. Theranostics. 2021;11(2):893\u2013905.","journal-title":"Theranostics"},{"issue":"1","key":"3949_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s13018-021-02300-0","volume":"16","author":"A Gupta","year":"2021","unstructured":"Gupta A, Maffulli N, Rodriguez HC, Lee CE, Levy HJ, El-Amin SF 3rd. Umbilical cord-derived Wharton\u2019s jelly for treatment of knee osteoarthritis: study protocol for a non-randomized, open-label, multi-center trial. J Orthop Surg Res. 2021;16(1):143.","journal-title":"J Orthop Surg Res"},{"issue":"5","key":"3949_CR40","doi-asserted-by":"publisher","first-page":"e391","DOI":"10.1097\/CCM.0000000000004285","volume":"48","author":"HK Yip","year":"2020","unstructured":"Yip HK, Fang WF, Li YC, Lee FY, Lee CH, Pei SN, Ma MC, Chen KH, Sung PH, Lee MS. Human umbilical cord-derived mesenchymal stem cells for acute respiratory distress syndrome. Crit Care Med. 2020;48(5):e391\u20139.","journal-title":"Crit Care Med"},{"key":"3949_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.coche.2018.08.004","volume":"22","author":"SC Galbraith","year":"2018","unstructured":"Galbraith SC, Bhatia H, Liu H, et al. Media formulation optimization: current and future opportunities. Curr Opin Chem Eng. 2018;22:42\u20137.","journal-title":"Curr Opin Chem Eng"},{"issue":"6","key":"3949_CR42","doi-asserted-by":"publisher","first-page":"31175","DOI":"10.1038\/srep31175","volume":"9","author":"Z Wei","year":"2016","unstructured":"Wei Z, Batagov AO, Carter DR, Krichevsky AM. Fetal bovine serum RNA interferes with the cell culture derived extracellular RNA. Sci Rep. 2016;9(6):31175.","journal-title":"Sci Rep"},{"issue":"6","key":"3949_CR43","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1111\/cpr.12063","volume":"46","author":"S Gottipamula","year":"2013","unstructured":"Gottipamula S, Muttigi MS, Kolkundkar U, Seetharam RN. Serum-free media for the production of human mesenchymal stromal cells: a review. Cell Prolif. 2013;46(6):608\u201327.","journal-title":"Cell Prolif"},{"issue":"2","key":"3949_CR44","doi-asserted-by":"publisher","first-page":"466","DOI":"10.3390\/cells10020466","volume":"10","author":"S Panella","year":"2021","unstructured":"Panella S, Muoio F, Jossen V, et al. Chemically defined xeno-and serum-free cell culture medium to grow human adipose stem cells. Cells. 2021;10(2):466.","journal-title":"Cells"},{"issue":"1","key":"3949_CR45","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13287-018-1058-z","volume":"9","author":"J Park","year":"2018","unstructured":"Park J, Lee JH, Yoon BS, Jun EK, Lee G, Kim IY, You S. Additive effect of bFGF and selenium on expansion and paracrine action of human amniotic fluid-derived mesenchymal stem cells. Stem Cell Res Ther. 2018;9(1):293.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"3949_CR46","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1634\/stemcells.2005-0191","volume":"24","author":"A Schmidt","year":"2006","unstructured":"Schmidt A, Ladage D, Schink\u00f6the T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RH, Staib P, Addicks K, Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells. 2006;24(7):1750\u20138.","journal-title":"Stem Cells"},{"issue":"1","key":"3949_CR47","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1089\/dna.2016.3411","volume":"36","author":"L Hosseinzadeh Anvar","year":"2017","unstructured":"Hosseinzadeh Anvar L, Hosseini-Asl S, Mohammadzadeh-Vardin M, Sagha M. The telomerase activity of selenium-induced human umbilical cord mesenchymal stem cells is associated with different levels of c-Myc and p53 expression. DNA Cell Biol. 2017;36(1):34\u201341.","journal-title":"DNA Cell Biol"},{"key":"3949_CR48","doi-asserted-by":"publisher","first-page":"101532","DOI":"10.1016\/j.molmet.2022.101532","volume":"63","author":"G Taurino","year":"2022","unstructured":"Taurino G, Deshmukh R, Villar VH, Chiu M, Shaw R, Hedley A, Shokry E, Sumpton D, Dander E, D\u2019Amico G, Bussolati O, Tardito S. Mesenchymal stromal cells cultured in physiological conditions sustain citrate secretion with glutamate anaplerosis. Mol Metab. 2022;63:101532.","journal-title":"Mol Metab"},{"issue":"1","key":"3949_CR49","doi-asserted-by":"publisher","first-page":"21583","DOI":"10.1038\/s41598-020-78395-y","volume":"10","author":"ME Al Masawa","year":"2020","unstructured":"Al Masawa ME, Wan Kamarul Zaman WS, Chua KH. Biosafety evaluation of culture-expanded human chondrocytes with growth factor cocktail: a preclinical study. Sci Rep. 2020;10(1):21583.","journal-title":"Sci Rep"},{"issue":"1","key":"3949_CR50","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13287-016-0352-x","volume":"7","author":"G Astori","year":"2016","unstructured":"Astori G, Amati E, Bambi F, Bernardi M, Chieregato K, Sch\u00e4fer R, Sella S, Rodeghiero F. Platelet lysate as a substitute for animal serum for the ex-vivo expansion of mesenchymal stem\/stromal cells: present and future. Stem Cell Res Ther. 2016;7(1):93.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3949_CR51","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/scrt97","volume":"3","author":"NB Azouna","year":"2012","unstructured":"Azouna NB, Jenhani F, Regaya Z, Berraeis L, Othman TB, Ducrocq E, Domenech J. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther. 2012;3(1):6.","journal-title":"Stem Cell Res Ther"},{"issue":"2","key":"3949_CR52","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.biomaterials.2009.09.043","volume":"31","author":"N Chevallier","year":"2010","unstructured":"Chevallier N, Anagnostou F, Zilber S, Bodivit G, Maurin S, Barrault A, Bierling P, Hernigou P, Layrolle P, Rouard H. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials. 2010;31(2):270\u20138.","journal-title":"Biomaterials"},{"issue":"8","key":"3949_CR53","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1038\/cddis.2013.295","volume":"4","author":"Y-H Rhee","year":"2013","unstructured":"Rhee Y-H, Choi M, Lee H-S, Park C-H, Kim S-M, Yi S-H, Oh S-M, Cha H-J, Chang M-Y, Lee S-H. Insulin concentration is critical in culturing human neural stem cells and neurons. Cell Death Dis. 2013;4(8):e766.","journal-title":"Cell Death Dis"},{"issue":"9","key":"3949_CR54","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo HC, Yu YC, Sung Y, Han JM. Glutamine reliance in cell metabolism. Exp Mol Med. 2020;52(9):1496\u2013516.","journal-title":"Exp Mol Med"},{"issue":"41","key":"3949_CR55","doi-asserted-by":"publisher","first-page":"39428","DOI":"10.1074\/jbc.M305542200","volume":"278","author":"Y Saito","year":"2003","unstructured":"Saito Y, Yoshida Y, Akazawa T, Takahashi K, Niki E. Cell death caused by selenium deficiency and protective effect of antioxidants. J Biol Chem. 2003;278(41):39428\u201334.","journal-title":"J Biol Chem"},{"issue":"2","key":"3949_CR56","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.molcel.2015.06.011","volume":"59","author":"M Gao","year":"2015","unstructured":"Gao M, Monian P, Quadri N, Ramasamy R, Jiang X. Glutaminolysis and transferrin regulate ferroptosis. Mol Cell. 2015;59(2):298\u2013308.","journal-title":"Mol Cell"},{"issue":"1","key":"3949_CR57","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/sctm.19-0202","volume":"9","author":"M Kabat","year":"2020","unstructured":"Kabat M, Bobkov I, Kumar S, Grumet M. Trends in mesenchymal stem cell clinical trials 2004\u20132018: is efficacy optimal in a narrow dose range? Stem Cells Transl Med. 2020;9(1):17\u201327.","journal-title":"Stem Cells Transl Med"},{"issue":"8","key":"3949_CR58","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.4103\/1673-5374.332151","volume":"17","author":"TT Cao","year":"2022","unstructured":"Cao TT, Chen H, Pang M, Xu SS, Wen HQ, Liu B, Rong LM, Li MM. Dose optimization of intrathecal administration of human umbilical cord mesenchymal stem cells for the treatment of subacute incomplete spinal cord injury. Neural Regen Res. 2022;17(8):1785\u201394.","journal-title":"Neural Regen Res"},{"issue":"5","key":"3949_CR59","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s11033-022-07194-7","volume":"49","author":"Z Eydian","year":"2022","unstructured":"Eydian Z, Mohammad Ghasemi A, Ansari S, Kamali AN, Khosravi M, Momtaz S, Riki S, Rafighdoost L, Entezari HR. Differentiation of multipotent stem cells to insulin-producing cells for treatment of diabetes mellitus: bone marrow- and adipose tissue-derived cells comparison. Mol Biol Rep. 2022;49(5):3539\u201348.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"3949_CR60","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1002\/stem.3077","volume":"38","author":"C M\u00e9nard","year":"2020","unstructured":"M\u00e9nard C, Dulong J, Roulois D, H\u00e9braud B, Verdi\u00e8re L, Pangault C, Sibut V, Bezier I, Bescher N, Monvoisin C, Gadelorge M, Bertheuil N, Fl\u00e9cher E, Casteilla L, Collas P, Senseb\u00e9 L, Bourin P, Espagnolle N, Tarte K. Integrated transcriptomic, phenotypic, and functional study reveals tissue-specific immune properties of mesenchymal stromal cells. Stem Cells. 2020;38(1):146\u201359.","journal-title":"Stem Cells"},{"issue":"11","key":"3949_CR61","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.reth.2019.01.002","volume":"10","author":"M Nakao","year":"2019","unstructured":"Nakao M, Inanaga D, Nagase K, Kanazawa H. Characteristic differences of cell sheets composed of mesenchymal stem cells with different tissue origins. Regen Ther. 2019;10(11):34\u201340.","journal-title":"Regen Ther"},{"issue":"2","key":"3949_CR62","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/scd.2017.0029","volume":"27","author":"R Donders","year":"2018","unstructured":"Donders R, Bogie JFJ, Ravanidis S, Gervois P, Vanheusden M, Mar\u00e9e R, Schrynemackers M, Smeets HJM, Pinxteren J, Gijbels K, Walbers S, Mays RW, Deans R, Van Den Bosch L, Stinissen P, Lambrichts I, Gyselaers W, Hellings N. Human Wharton\u2019s jelly-derived stem cells display a distinct immunomodulatory and proregenerative transcriptional signature compared to bone marrow-derived stem cells. Stem Cells Dev. 2018;27(2):65\u201384.","journal-title":"Stem Cells Dev"},{"issue":"7","key":"3949_CR63","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1016\/j.jcyt.2015.03.608","volume":"17","author":"UG Thakkar","year":"2015","unstructured":"Thakkar UG, Trivedi HL, Vanikar AV, Dave SD. Insulin-secreting adipose-derived mesenchymal stromal cells with bone marrow-derived hematopoietic stem cells from autologous and allogenic sources for type 1 diabetes mellitus. Cytotherapy. 2015;17(7):940\u20137.","journal-title":"Cytotherapy"},{"issue":"8","key":"3949_CR64","doi-asserted-by":"publisher","first-page":"e43255","DOI":"10.1371\/journal.pone.0043255","volume":"7","author":"N Fekete","year":"2012","unstructured":"Fekete N, Rojewski MT, F\u00fcrst D, Kreja L, Ignatius A, Dausend J, Schrezenmeier H. GMP-compliant isolation and large-scale expansion of bone marrow-derived MSC. PLoS ONE. 2012;7(8):e43255.","journal-title":"PLoS ONE"},{"issue":"8","key":"3949_CR65","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1002\/bit.25582","volume":"112","author":"TR Heathman","year":"2015","unstructured":"Heathman TR, Glyn VA, Picken A, Rafiq QA, Coopman K, Nienow AW, Kara B, Hewitt CJ. Expansion, harvest and cryopreservation of human mesenchymal stem cells in a serum-free microcarrier process. Biotechnol Bioeng. 2015;112(8):1696\u2013707.","journal-title":"Biotechnol Bioeng"},{"issue":"10","key":"3949_CR66","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/j.yexcr.2013.04.004","volume":"319","author":"K Crapnell","year":"2013","unstructured":"Crapnell K, Blaesius R, Hastings A, Lennon DP, Caplan AI, Bruder SP. Growth, differentiation capacity, and function of mesenchymal stem cells expanded in serum-free medium developed via combinatorial screening. Exp Cell Res. 2013;319(10):1409\u201318.","journal-title":"Exp Cell Res"},{"issue":"5","key":"3949_CR67","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/cpr.12279","volume":"49","author":"X Wu","year":"2016","unstructured":"Wu X, Kang H, Liu X, Gao J, Zhao K, Ma Z. Serum and xeno-free, chemically defined, no-plate-coating-based culture system for mesenchymal stromal cells from the umbilical cord. Cell Prolif. 2016;49(5):579\u201388.","journal-title":"Cell Prolif"},{"issue":"3","key":"3949_CR68","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/en.2015-1297","volume":"157","author":"A Youssef","year":"2016","unstructured":"Youssef A, Han VK. Low oxygen tension modulates the insulin-like growth factor-1 or -2 signaling via both insulin-like growth factor-1 receptor and insulin receptor to maintain stem cell Identity in placental mesenchymal stem cells. Endocrinology. 2016;157(3):1163\u201374.","journal-title":"Endocrinology"},{"issue":"4","key":"3949_CR69","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1210\/en.2013-1842","volume":"155","author":"A Youssef","year":"2014","unstructured":"Youssef A, Iosef C, Han VK. Low-oxygen tension and IGF-I promote proliferation and multipotency of placental mesenchymal stem cells (PMSCs) from different gestations via distinct signaling pathways. Endocrinology. 2014;155(4):1386\u201397.","journal-title":"Endocrinology"},{"issue":"1","key":"3949_CR70","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/scrt97","volume":"3","author":"N Ben Azouna","year":"2012","unstructured":"Ben Azouna N, Jenhani F, Regaya Z, Berraeis L, Ben Othman T, Ducrocq E, Domenech J. Phenotypical and functional characteristics of mesenchymal stem cells from bone marrow: comparison of culture using different media supplemented with human platelet lysate or fetal bovine serum. Stem Cell Res Ther. 2012;3(1):6.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"3949_CR71","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3892\/ijmm.2013.1555","volume":"33","author":"J Stern-Straeter","year":"2014","unstructured":"Stern-Straeter J, Bonaterra GA, Juritz S, Birk R, Goessler UR, Bieback K, Bugert P, Schultz J, H\u00f6rmann K, Kinscherf R, Faber A. Evaluation of the effects of different culture media on the myogenic differentiation potential of adipose tissue- or bone marrow-derived human mesenchymal stem cells. Int J Mol Med. 2014;33(1):160\u201370.","journal-title":"Int J Mol Med"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03949-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03949-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:29:13Z","timestamp":1727454553000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03949-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,27]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3949"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03949-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,27]]},"assertion":[{"value":"26 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been approved by the Ethics Committee of The Third Affiliated Hospital of Sun Yat-sen University. Informed consent was obtained from healthy donors prior to the collection of UCs. The research project titled \u201cMulti-center randomized controlled clinical study of allogeneic human umbilical cord mesenchymal stem cells in the treatment of hepatitis B related chronic and acute liver dysfunction\u201d was approved on December 30, 2020 (approval number: 202014).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"327"}}